ClinicalTrials.gg
Sign In

Chinook Therapeutics, Inc. clinical trials

Acquired by Novartis, Aug 11, 2023 · source ↗

The registry lists 3 studies whose lead sponsor is Chinook Therapeutics, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 3, 2023.

Before and after it joined Novartis

First submitted before Chinook Therapeutics, Inc. became part of Novartis
3
First submitted after Chinook Therapeutics, Inc. became part of Novartis
0
Unclear, or no submission date
0

By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.

What it is testing

The drugs Chinook Therapeutics, Inc.’s studies test, most studies first; none is open now — 1 drug with a page of their own. Each count opens the studies in search.

Studies, none open

All 3 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Completed133%
  • Stopped early267%

Phase

  • Phase 13
  • Phase 21

Where

  • United States3

Over the years

  1. 17
  2. 18
  3. 19
  4. 20
  5. 21
  6. 222
  7. 23
  8. 24
  9. 25
  10. 026

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

  • Chinook Therapeutics, Inc.3 studies

Something wrong with this grouping? Tell us on the Novartis page.

Studies

Recruiting first, then most recently updated. Showing 3 of 3. All Novartis studies →